Results 221 to 230 of about 346,103 (330)

The road not taken: Exploring non-transplant options in De Novo philadelphia positive acute myeloid leukemia. [PDF]

Leuk Res Rep
Sharif MI, Alotaibi AS, Alyamany R, Alahmari A, Alkhaldi H, Saad A, Alfayez M.   +6 more
europepmc   +1 more source

Breaking barriers: Smart vaccine platforms for cancer immunomodulation

Cancer Communications, EarlyView.
Abstract Despite significant advancements in cancer treatment, current therapies often fail to completely eradicate malignant cells. This shortfall underscores the urgent need to explore alternative approaches such as cancer vaccines. Leveraging the immune system's natural ability to target and kill cancer cells holds great therapeutic potential ...
Mohammad Mahmoudi Gomari, Taha Ghantabpour, Nima Pourgholam, Neda Rostami, Stephen M. Hatfield, Farzaneh Namazifar, Shadi Abkhiz, Seyed Sadegh Eslami, Mahsa Ramezanpour, Mahsa Darestanifarahani, Igor Astsaturov, Sidi A. Bencherif    +11 more
wiley   +1 more source

A shadow in the treatment of acute leukemia: lineage switch. [PDF]

Blood Sci
Zhou Q, Wang Y.
europepmc   +1 more source

Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities

Cancer Communications, EarlyView.
Abstract Copper, one of the essential nutrients for the human body, acts as an electron relay in multiple pathways due to its redox properties. Both deficiencies and excesses of copper lead to cellular fragility. Therefore, it can manifest pro‐ and anti‐cancer properties in tumors. Therefore, it is crucial to clarify the copper activity within the cell.
Dan Shan, Jinling Song, Yuqing Ren, Yuyuan Zhang, Yuhao Ba, Peng Luo, Quan Cheng, Hui Xu, Siyuan Weng, Anning Zuo, Shutong Liu, Xinwei Han, Jinhai Deng, Zaoqu Liu   +13 more
wiley   +1 more source

m6A hypermethylation of TCF-1 regulated by METTL16 promotes acute myeloid leukemia. [PDF]

Clin Exp Med
Li J, Kang H.
europepmc   +1 more source

Assessment of chromatin remodeling of acute myeloid leukemia cells treated with gilteritinib: a case report. [PDF]

J Med Case Rep
Mori J, Sawada T, Nojiri K, Kanemoto Y, Okada T, Kurokawa T, Kato S.   +6 more
europepmc   +1 more source

Long noncoding RNAs in acute myeloid leukemia: biomarkers, prognostic indicators, and treatment potential. [PDF]

Cancer Cell Int
Farajzadeh M, Fathi M, Jalali P, Mahmoudsalehi Kheshti A, Khodayari S, Hojjat-Farsangi M, Jadidi F.   +6 more
europepmc   +1 more source

Trends and Outcomes Following Percutaneous Coronary Intervention in Patients With Myeloproliferative Neoplasms: Insights From National Database

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Myeloproliferative neoplasms (MPN) are associated with an increased cardiovascular risk including acute coronary syndrome. However, there is a lack of comprehensive data regarding the rate of percutaneous coronary intervention (PCI), as well as the in‐hospital characteristics and outcomes for MPN patients.
Song Peng Ang, Jia Ee Chia, Chayakrit Krittanawong, Robert N. Piana, Kwan Lee, Chadi Ayoub, JR Exequiel Pineda, David Song, Debabrata Mukherjee   +8 more
wiley   +1 more source

Cerebral myeloid sarcoma (Chloroma): Report of a rare entity. [PDF]

Int J Surg Case Rep
Hermassi MA, Ghedira K, Bouzouita K, Zehani A, Bouali S, Abderrahmen K.   +5 more
europepmc   +1 more source

Mitochondria‐Catalyzed Activation of Anticancer Prodrugs

ChemCatChem, EarlyView.
Prodrug C is a water soluble, monomeric compound accumulating in mitochondria of cancer cells, where it is activated in the reaction with mitochondrial H2O2. The activation leads to the release of camptothecin that causes cell cycle arrest in G2 phase and cancer cell death.
Michael Raucheisen, Dina Attia, Marlies Körber, Alejandra Aroca Crevillén, Andrés Hidalgo, Frank Beierlein, Petra Imhof, Andriy Mokhir   +7 more
wiley   +1 more source